Concepedia

Mark C. Wenlock

MC

Statistics

Publications

14

Citations

1.4K

H-Index

12

Active since

2002

Affiliations

AstraZeneca (United Kingdom)(Current)

Loughborough University

AstraZeneca (Sweden)

Mark C. Wenlock is an author at AstraZeneca (United Kingdom) specializing in pharmacy, drug discovery, and pharmacology.

ORCID

Publications per year

2002–2021

14

Publications

14

A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs

Mark C. Wenlock, Rupert P. Austin, Patrick Barton et al. · Journal of Medicinal Chemistry · 2003 · 537 citations

, , +17

The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical Properties

Rupert P. Austin, Patrick Barton, Scott L. Cockroft et al. · Drug Metabolism and Disposition · 2002 · 407 citations

, , +17

Impact of ion class and time on oral drug molecular properties

Paul D. Leeson, Stephen A. St-Gallay, Mark C. Wenlock · MedChemComm · 2010 · 83 citations

, , +10

A Method for Measuring the Lipophilicity of Compounds in Mixtures of 10

Mark C. Wenlock, Tim Potter, Patrick Barton et al. · SLAS DISCOVERY · 2011 · 71 citations · Full text

, , +11

How Experimental Errors Influence Drug Metabolism and Pharmacokinetic QSAR/QSPR Models

Mark C. Wenlock, Lars Carlsson · Journal of Chemical Information and Modeling · 2014 · 59 citations · Full text

, , +13

1–5 of 14